Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-19

FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA supplemental application for CHANTIX (varenicline tartrate) submitted by Pfizer to modify the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)

Snippet

SUPPL AP for CHANTIX (VARENICLINE TARTRATE)